Gilead CCO Sells $366K in GILD Stock via 10b5-1 Plan
GILEAD SCIENCES, INC.
Subscribe to track GILD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Gilead CCO Sells $366K in GILD Stock
Company: GILEAD SCIENCES, INC. (GILD) Form: 4 | Filed: 2025-12-16 Significance: Low
Insider: Mercier Johanna Title: Chief Commercial Officer | Relationship: Officer
Transaction: • Type: Sell • Shares: 3,000 • Price: $122.00 • Value: $366,000 • Owned After: 106,221
Key Insight: This is a routine, pre-scheduled sale under a 10b5-1 plan, representing a negligible fraction of the company's market cap and the insider's total holdings.
Market Context: The transaction size is immaterial relative to Gilead's $155.11B market capitalization.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: GILEAD SCIENCES, INC. (GILD)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A minor, pre-scheduled sale by the Chief Commercial Officer under a Rule 10b5-1 plan, indicating low informational value.
- Market Impact: The transaction is too small to have any meaningful impact on the stock.
Company Information
| Field | Value |
|---|---|
| Company | GILEAD SCIENCES, INC. |
| Ticker Symbol | GILD |
| CIK | 0000882095 |
| Industry | BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) |
Insider Information
| Field | Value |
|---|---|
| Name | Mercier Johanna |
| CIK | 0001782135 |
| Title/Position | Chief Commercial Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-12-15 |
| Transaction Code | S (Open market or private sale) |
| Security Type | Common Stock |
| Shares Involved | 3,000 |
| Price Per Share | $122.00 |
| Total Value | $366,000 |
| Shares Owned After | 106,221 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $366,000 |
| % of Market Cap | 0.00024% |
| Shares Transacted | 3,000 |
| % of Shares Outstanding | 0.00024% |
| Post-Transaction Ownership | 106,221 shares (0.0086% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a mega-cap company like Gilead with a $155.11 billion market capitalization, a transaction of $366,000 is financially immaterial.
- Ownership Concentration: The sale represents a very small fraction (2.75%) of the insider's direct holdings and does not significantly alter her ownership stake.
- Transaction Significance: The transaction's value is less than 0.001% of the company's market cap and outstanding shares, placing it well below any threshold of significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The sale is minor in size and was executed under a pre-scheduled 10b5-1 plan, which negates any inference of new negative information.
Volume & Sentiment
- Expected Volume Impact: Negligible. The 3,000 shares transacted will be absorbed by the market without notice.
- Sentiment Indicator: Neutral. This is a routine, non-eventful filing.
Additional Context
Transaction Notes
- Special Circumstances: The filing explicitly states the sale was made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. This indicates the sale was planned far in advance and is not based on recent events.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.